Tapewire

Nasdaq · USD

AIDX

20/20 Biolabs, Inc.

Export transactions ↓
Tapewire entity
8097
SEC CIK
0001139685
Parsed reports
17

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 02, 2026 Filed Apr 6, 2026 21:56 UTC
Bergman Alan B.Chief Financial Officer
GrantStock Option · Derivative 100,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001213900-26-040583 · ownership.xml · derivative · entry 1

Bergman Alan B. · CIK 0001907908 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-04-02

F1 · security: 25,000 of the shares subject to the stock option will vest on the first anniversary of the date of grant and the remaining shares will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service to the Issuer.

F1 · kind: 25,000 of the shares subject to the stock option will vest on the first anniversary of the date of grant and the remaining shares will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service to the Issuer.

F1 · derivative.exercise_date: 25,000 of the shares subject to the stock option will vest on the first anniversary of the date of grant and the remaining shares will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service to the Issuer.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 21:56 UTC
Zhou JimingChief Operating Officer
GrantStock Option · Derivative 150,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001213900-26-040581 · ownership.xml · derivative · entry 1

Zhou Jiming · CIK 0002109760 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2036-04-02

Read SEC document
March 03, 2026 Filed Mar 4, 2026 22:48 UTC
Cohen Jonathan MDirector · Chief Executive Officer · 10% owner
GrantStock Option · Derivative 352,936 $0.00 Strike: $3.39 $0.00
Disclosure

SEC source: 0001213900-26-023758 · ownership.xml · derivative · entry 1

Cohen Jonathan M · CIK 0002111543 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,936

Underlying: Common Stock · 352,936 shares

Expires 2036-03-03

F1 · security: On March 3, 2026, the Reporting Person was granted a stock option for the purchase of 352,936 shares of common stock, which shall vest in equal quarterly installments over the following four (4) years, subject to the Reporting Person's continuous service to the Issuer.

F1 · derivative.exercise_date: On March 3, 2026, the Reporting Person was granted a stock option for the purchase of 352,936 shares of common stock, which shall vest in equal quarterly installments over the following four (4) years, subject to the Reporting Person's continuous service to the Issuer.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 23:13 UTC ConversionSeries A-2 Preferred Stock · Derivative 7,700 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-019421 · ownership.xml · derivative · entry 2

COHEN RICHARD M · CIK 0001075891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,700 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.exercise_price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.exercise_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.expiration_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 23:13 UTC ConversionCommon Stock 7,700 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-019421 · ownership.xml · nonDerivative · entry 1

COHEN RICHARD M · CIK 0001075891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 24, 2026 00:09 UTC ConversionSeries A-2 Preferred Stock · Derivative 6,135 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-019456 · ownership.xml · derivative · entry 4

Rollins John Woodson · CIK 0002112941 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,135 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F2 · derivative.exercise_price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F2 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F2 · price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F2 · derivative.exercise_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F2 · derivative.expiration_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 24, 2026 00:09 UTC ConversionSeries A Preferred Stock · Derivative 13,029 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-019456 · ownership.xml · derivative · entry 3

Rollins John Woodson · CIK 0002112941 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,029 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date.

F1 · derivative.exercise_price: On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date.

F1 · kind: On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date.

F1 · price: On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date.

F1 · derivative.exercise_date: On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date.

F1 · derivative.expiration_date: On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 24, 2026 00:09 UTC ConversionCommon Stock 6,135 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-019456 · ownership.xml · nonDerivative · entry 2

Rollins John Woodson · CIK 0002112941 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 24, 2026 00:09 UTC ConversionCommon Stock 13,029 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-019456 · ownership.xml · nonDerivative · entry 1

Rollins John Woodson · CIK 0002112941 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,140

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 23:13 UTC ConversionSeries A-2 Preferred Stock · Derivative 31 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-019424 · ownership.xml · derivative · entry 2

Ross Michael A. · CIK 0002109744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.exercise_price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.exercise_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.expiration_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 23:13 UTC ConversionCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-019424 · ownership.xml · nonDerivative · entry 1

Ross Michael A. · CIK 0002109744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 23:13 UTC ConversionSeries A-2 Preferred Stock · Derivative 7,669 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-019423 · ownership.xml · derivative · entry 2

Compton John G. · CIK 0002107487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,669 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.exercise_price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · price: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.exercise_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

F1 · derivative.expiration_date: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 23:13 UTC ConversionCommon Stock 7,669 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-019423 · ownership.xml · nonDerivative · entry 1

Compton John G. · CIK 0002107487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,335

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.